To see this page, please, enable javaScript and styleSheets on your browser: Tools -> Internet Options ...
Reload !
Gene NUBP2TABLE OF CONTENTS / OPEN CLOSE ALL PARAGRAPHS
Summary back to top
Compact gene diagram back to top
407 supporting clones for gene NUBP2 back to top
cDNA accession
Links to the sequence
Tissue

most 5' clones
in red
Match
mRNA
From bp
to bp
in mRNA
From bp
to bp
in accs.
Clone encodes
complete protein
(with AA variation)
Features Anomalies
detected by
AceView
Accession
match over
(% length)
Base differences
relative to genome
(% identity)
AW246412 lung, small cell carcinoma .a 1 to 529 10 to 538   tiling clone,   529/538
(98 %)
7 diff
(98.7 %id)
BE267243 lung, small cell carcinoma .a 22 to 827 1 to 805   tiling clone,   805/950
(84 %)
22 diff
(97.7 %id)
CR992440 T-Lymphocytes .a 28 to 650 1 to 623   tiling clone,   623/623
(100 %)
0 diff
(100 %id)
BM011803 brain, neuroblastoma, cell line .a 35 to 740 13 to 720   tiling clone,   708/720
(98 %)
17 diff
(97.7 %id)
TI_59380978   .a 35 to 740 115 to 822       708/719
(98 %)
17 diff
(97.7 %id)
AW246651 lung, small cell carcinoma .a 1133 to 1571 449 to 11   tiling clone, AAA   439/439
(100 %)
4 diff
(99.1 %id)
BQ052153 blood, natural killer cells, cell line .b 1 to 735 1 to 740   tiling clone,   740/1073
(68 %)
40 diff
(96.3 %id)
BQ052313 blood, natural killer cells, cell line .b 1 to 897 1 to 912   tiling clone,   912/1066
(85 %)
46 diff
(95.7 %id)
BQ053326 blood, natural killer cells, cell line .b 1 to 972 1 to 989 W35L E36G H38A H39P L40S ... tiling clone,   989/1040
(95 %)
26 diff
(97.5 %id)
BQ054094 blood, natural killer cells, cell line .b 1 to 797 1 to 803   tiling clone,   803/1042
(77 %)
13 diff
(98.8 %id)
BE747742 adenocarcinoma cell line, ovary .c 1 to 724 26 to 747   tiling clone,   722/1014
(71 %)
24 diff
(97.7 %id)
BU189242 melanotic melanoma, skin .c 31 to 786 1 to 758   tiling clone,   758/867
(87 %)
10 diff
(98.9 %id)
NM_012225.2   .c 40 to 1420 1 to 1381 exact RefSeq, AAA   1381/1381
(100 %)
0 diff
(100 %id)
BG387344 adenocarcinoma cell line, colon .c 46 to 614 1 to 570       570/571
(99 %)
5 diff
(99.2 %id)
CN356640 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .c 47 to 371 1 to 325       325/325
(100 %)
3 diff
(99.1 %id)
BF314050 brain, neuroblastoma .c 48 to 792 1 to 741       739/966
(76 %)
23 diff
(97.7 %id)
BI602765 brain, hypothalamus .c 48 to 799 1 to 751       751/755
(99 %)
12 diff
(98.5 %id)
BC008005 Brain, neuroblastoma .c 49 to 1415 1 to 1367 exact tiling clone, available from MGC, AAA   1367/1367
(100 %)
5 diff
(99.7 %id)
TI_45212478   .c 51 to 799 88 to 835       748/839
(89 %)
13 diff
(98.5 %id)
BG823456 adenocarcinoma cell line, colon .c 52 to 552 1 to 506       503/506
(99 %)
14 diff
(97.3 %id)
BG818455 anaplastic oligodendroglioma with 1p/19qloss, brain .c 52 to 700 1 to 665       665/718
(92 %)
27 diff
(96.3 %id)
AK001023 whole embryo, mainly head .c 55 to 1420 1 to 1366 F242S available from FLJ,   1366/1366
(100 %)
6 diff
(99.6 %id)
BP215492 corpus callosum .c 55 to 636 1 to 582       582/582
(100 %)
0 diff
(100 %id)
BP227945   .c 55 to 617 1 to 561       561/561
(100 %)
1 diff
(99.9 %id)
BP300034   .c 55 to 636 1 to 581       581/581
(100 %)
2 diff
(99.7 %id)
CB127361 cervix, Uterine .c 56 to 415 1 to 360       360/360
(100 %)
1 diff
(99.8 %id)
AU118415 whole embryo, mainly head .c 56 to 732 2 to 673   capped   672/725
(92 %)
12 diff
(98.4 %id)
BP341919 stomach mucosa .c 59 to 612 1 to 554       554/554
(100 %)
3 diff
(99.5 %id)
BP324358 Pancreas .c 62 to 645 1 to 582       582/582
(100 %)
2 diff
(99.7 %id)
AF118394   .c 66 to 1415 1 to 1351 exact     1351/1351
(100 %)
9 diff
(99.4 %id)
BP311697 brain .c 67 to 647 1 to 583       583/583
(100 %)
22 diff
(96.3 %id)
CN356645 embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells .c 68 to 516 43 to 492       450/492
(91 %)
10 diff
(98.0 %id)
CR619719 T cells (Jurkat cell line) .c 68 to 1377 1 to 1310 exact     1310/1310
(100 %)
0 diff
(100 %id)
AL557437 T cells (Jurkat cell line), T cells from T cell leukemia .c 69 to 648 1 to 579   fully sequenced,   579/579
(100 %)
5 diff
(99.2 %id)
BP366708 thymus .c 70 to 643 1 to 574       574/574
(100 %)
12 diff
(98.0 %id)
BM009527 amelanotic melanoma, cell line, skin .c 71 to 697 1 to 627       627/627
(100 %)
1 diff
(99.9 %id)
BM009565 amelanotic melanoma, cell line, skin .c 71 to 665 1 to 595       595/596
(99 %)
8 diff
(98.7 %id)
BM010632 amelanotic melanoma, cell line, skin .c 71 to 631 1 to 561       561/564
(99 %)
4 diff
(99.3 %id)
BM809454 amelanotic melanoma, cell line, skin .c 72 to 797 26 to 750       725/1314
(55 %)
9 diff
(99.4 %id)
BM555949 amelanotic melanoma, cell line, skin .c 72 to 925 1 to 863       863/1160
(74 %)
26 diff
(97.8 %id)
BM913444 amelanotic melanoma, cell line, skin .c 72 to 809 25 to 768       744/1079
(68 %)
19 diff
(98.3 %id)
TI_59384276   .c 72 to 697 61 to 686       626/626
(100 %)
0 diff
(100 %id)
TI_59384322   .c 72 to 665 63 to 656       594/595
(99 %)
7 diff
(98.9 %id)
TI_59385469   .c 72 to 631 63 to 622       560/563
(99 %)
3 diff
(99.5 %id)
BM475413 eye, retinoblastoma .c 73 to 726 1 to 655       655/1123
(58 %)
7 diff
(99.4 %id)
BC002768 Ovary, adenocarcinoma .c 74 to 1415 1 to 1342 exact available from MGC, AAA   1342/1342
(100 %)
4 diff
(99.8 %id)
CB141962 Liver .c 75 to 189 1 to 115       115/115
(100 %)
1 diff
(99.2 %id)
BP381836 adipose tissue .c 76 to 694 1 to 619       619/619
(100 %)
8 diff
(98.8 %id)
TI_43961007   .c 76 to 936 52 to 910       859/962
(89 %)
39 diff
(96.0 %id)
CN356641 embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells .c 77 to 688 1 to 612       612/612
(100 %)
3 diff
(99.6 %id)
CA495403   .c 77 to 950 1 to 884 E212R E213G L214A A215G Q216P ...     884/888
(99 %)
19 diff
(97.9 %id)
BI823699 pooled brain, lung, testis .c 78 to 729 1 to 658       656/922
(71 %)
15 diff
(98.4 %id)
BM459627 leiomyosarcoma, uterus .c 78 to 900 1 to 832       832/928
(89 %)
12 diff
(98.8 %id)
BQ056108 lymph, lymphoma, cell line .c 78 to 725 1 to 650       650/1059
(61 %)
12 diff
(98.9 %id)
TI_57202474   .c 78 to 729 59 to 716       656/980
(66 %)
24 diff
(97.6 %id)
TI_57234649   .c 78 to 935 26 to 888       863/891
(96 %)
31 diff
(96.6 %id)
BG176928 lymph, lymphoma, cell line .c 79 to 798 1 to 726       726/993
(73 %)
27 diff
(97.3 %id)
BG423108 Kidney, renal cell adenocarcinoma .c 79 to 729 1 to 659       659/934
(70 %)
20 diff
(97.9 %id)
BG746765 adenocarcinoma cell line, colon .c 79 to 718 1 to 643       643/645
(99 %)
11 diff
(98.3 %id)
BI490079 pooled brain, lung, testis .c 79 to 936 1 to 856       856/908
(94 %)
33 diff
(96.4 %id)
BQ425238 eye, retinoblastoma .c 79 to 711 1 to 635       635/899
(70 %)
21 diff
(97.7 %id)
BQ717860 sympathetic trunk .c 79 to 615 33 to 574       542/850
(63 %)
20 diff
(97.7 %id)
BM542031 melanotic melanoma, skin .c 80 to 700 1 to 623       623/1187
(52 %)
22 diff
(98.2 %id)
BQ686751 ductal carcinoma, cell line, Pancreas .c 80 to 941 1 to 874       874/924
(94 %)
27 diff
(97.1 %id)
BQ949274 large cell carcinoma, lung .c 80 to 1033 1 to 965 E212R E213G L214A A215G Q216P ...     965/966
(99 %)
25 diff
(97.5 %id)
BU552469 carcinoma, cell line, Prostate .c 81 to 974 1 to 908 G27X K28E S29K T30H I31H ...     908/914
(99 %)
18 diff
(98.1 %id)
BF568258 epithelioid carcinoma cell line, Pancreas .c 83 to 759 1 to 675   fully sequenced,   675/675
(100 %)
10 diff
(98.6 %id)
BM047072 carcinoma, cell line, Prostate .c 83 to 687 1 to 610       610/791
(77 %)
13 diff
(98.4 %id)
BI908727 leukocyte .c 84 to 809 1 to 728       728/860
(84 %)
15 diff
(98.3 %id)
BU192743 eye, retinoblastoma .c 84 to 797 1 to 730       730/878
(83 %)
28 diff
(96.9 %id)
BE906148 epithelioid carcinoma, Pancreas .c 85 to 819 1 to 738       738/738
(100 %)
17 diff
(97.7 %id)
BU541564 carcinoma, cell line, Prostate .c 85 to 932 1 to 854       854/917
(93 %)
18 diff
(98.1 %id)
AK315611 skeletal muscle .c 90 to 944 1 to 855 K28R T180M     855/855
(100 %)
4 diff
(99.6 %id)
BP356308   .c 90 to 673 1 to 583       583/583
(100 %)
2 diff
(99.7 %id)
DA005692   .c 91 to 617 2 to 527   capped   526/526
(100 %)
0 diff
(100 %id)
DA617751   .c 91 to 617 2 to 527   capped   526/526
(100 %)
1 diff
(99.9 %id)
DA847275 placenta .c 91 to 634 2 to 545   capped   544/544
(100 %)
1 diff
(99.9 %id)
DA900177 skeletal muscle .c 91 to 617 2 to 527   capped   526/526
(100 %)
2 diff
(99.7 %id)
BE514803 adenocarcinoma cell line, ovary .c 92 to 618 1 to 542       542/550
(98 %)
15 diff
(97.3 %id)
CN356646 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .c 93 to 571 1 to 480       480/480
(100 %)
3 diff
(99.4 %id)
BG756201 B-cells, primary B-cells from tonsils (cell line) .c 93 to 951 1 to 861 V188R E189G N190E M191Y S192E ...     859/932
(92 %)
20 diff
(97.9 %id)
BG757916 B-cells, primary B-cells from tonsils (cell line) .c 93 to 877 1 to 780       780/883
(88 %)
16 diff
(98.2 %id)
CN356638 embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells .c 94 to 597 13 to 516       504/516
(97 %)
8 diff
(98.5 %id)
BE892428 melanotic melanoma, skin .c 94 to 729 1 to 634       634/637
(99 %)
7 diff
(99.0 %id)
BG031562 breast, mammary adenocarcinoma, cell line .c 94 to 877 1 to 783       783/1126
(69 %)
17 diff
(98.5 %id)
CF145766 CNCAP(3)T-225 cell line, Prostate .c 94 to 327 1 to 234       234/235
(99 %)
15 diff
(93.7 %id)
TI_57188192   .c 94 to 977 48 to 928 F194S T195P C196A P197H H198T ...     881/882
(99 %)
33 diff
(96.3 %id)
CR597386 T cells (Jurkat cell line) Cot10-normalized .c 95 to 1386 1 to 1292 exact tiling clone,   1292/1292
(100 %)
0 diff
(100 %id)
AL558931 T cells from T cell leukemia .c 95 to 1091 1 to 994 E2X A3X P7X I16X L18X ...     994/994
(100 %)
18 diff
(98.2 %id)
BX345215   .c 95 to 809 1 to 715       715/858
(83 %)
13 diff
(98.5 %id)
BX402827   .c 95 to 937 1 to 842       842/842
(100 %)
7 diff
(99.2 %id)
BI223648 cervical carcinoma cell line, cervix .c 95 to 929 1 to 823       823/834
(98 %)
26 diff
(96.9 %id)
BI859470 breast, mammary adenocarcinoma, cell line .c 95 to 977 1 to 880 F194S T195P C196A P197H H198T ...     880/881
(99 %)
33 diff
(96.3 %id)
BQ889330 epidermoid carcinoma, cell line, salivary gland .c 95 to 881 1 to 797       797/910
(87 %)
21 diff
(97.7 %id)
BQ671355 epidermoid carcinoma, cell line, salivary gland .c 95 to 799 1 to 709       709/953
(74 %)
20 diff
(98.0 %id)
BE742415 adenocarcinoma cell line, ovary .c 96 to 719 1 to 625       625/625
(100 %)
2 diff
(99.7 %id)
BE744461 adenocarcinoma cell line, ovary .c 96 to 805 1 to 705       707/766
(92 %)
14 diff
(98.2 %id)
BE745416 adenocarcinoma cell line, ovary .c 96 to 784 1 to 694       694/694
(100 %)
6 diff
(99.2 %id)
BM544860 ovary (pool of 3) .c 99 to 939 20 to 878       859/1179
(72 %)
40 diff
(96.7 %id)
TI_154178038   .c 101 to 796 68 to 761       694/906
(76 %)
32 diff
(96.5 %id)
BM913997 astrocytoma grade IV, cell line, brain .c 102 to 997 1 to 905 E212R E213G L214A A215G Q216P ...     905/1088
(83 %)
28 diff
(97.5 %id)
BG422403 Kidney, renal cell adenocarcinoma .c 107 to 709 1 to 602       602/933
(64 %)
10 diff
(99.0 %id)
BG823833 adenocarcinoma cell line, colon .c 107 to 740 1 to 643       643/847
(75 %)
20 diff
(97.7 %id)
AL702264 human skeletal muscle .c 108 to 462 1 to 355       355/357
(99 %)
7 diff
(98.1 %id)
BG474478 eye, retinoblastoma .c 108 to 729 1 to 622       622/784
(79 %)
9 diff
(98.9 %id)
DT219837 brain .c 109 to 758 1 to 650       650/650
(100 %)
1 diff
(99.9 %id)
BG474336 eye, retinoblastoma .c 110 to 747 1 to 649       649/1098
(59 %)
27 diff
(97.6 %id)
CD671583 eye, Iris .c 112 to 705 1 to 594       594/594
(100 %)
1 diff
(99.9 %id)
BF568283 epithelioid carcinoma cell line, Pancreas .c 114 to 737 1 to 623       623/845
(73 %)
11 diff
(98.7 %id)
BU173727 melanotic melanoma, cell line, skin .c 118 to 799 1 to 683       683/901
(75 %)
10 diff
(98.9 %id)
BQ669313 epidermoid carcinoma, cell line, salivary gland .c 118 to 662 1 to 551       551/863
(63 %)
17 diff
(98.1 %id)
BM921386 pooled brain, lung, testis .c 120 to 862 1 to 745       745/1058
(70 %)
20 diff
(98.2 %id)
CR735378 blood, natural killer cells, cell line .c 123 to 632 37 to 546       510/546
(93 %)
7 diff
(98.8 %id)
CD580501 brain .c 123 to 737 13 to 627       615/902
(68 %)
14 diff
(98.5 %id)
BQ054232 blood, natural killer cells, cell line .c 125 to 1065 1 to 947 G224X R234X E237X E245S F246S ...     947/1068
(88 %)
19 diff
(98.3 %id)
CV807393 Blastocyst, pluripotent cell line derived fromblastocyst inner cell mass .c 125 to 724 1 to 607       607/871
(69 %)
51 diff
(94.2 %id)
TI_1948074319   .c 126 to 648 130 to 652   fully sequenced,   523/652
(80 %)
7 diff
(99.0 %id)
TI_1948074505   .c 126 to 555 126 to 555   fully sequenced,   430/555
(77 %)
7 diff
(98.8 %id)
TI_1948074693   .c 126 to 553 125 to 552   fully sequenced,   428/552
(77 %)
7 diff
(98.8 %id)
TI_1948074877   .c 126 to 648 126 to 648   fully sequenced,   523/648
(80 %)
9 diff
(98.7 %id)
BG491104 large cell carcinoma, lung .c 127 to 949 1 to 828 A156C R183A V184G M185D I187N ...     828/902
(91 %)
41 diff
(95.5 %id)
BG574475 breast, mammary adenocarcinoma, cell line .c 127 to 838 1 to 712       712/712
(100 %)
3 diff
(99.6 %id)
TI_45133400   .c 127 to 737 62 to 676       615/813
(75 %)
19 diff
(97.7 %id)
BY995925   .c 127 to 755 8 to 636       629/636
(98 %)
6 diff
(99.1 %id)
BI161238 epithelioid carcinoma cell line, Pancreas .c 128 to 733 1 to 610       610/890
(68 %)
18 diff
(98.0 %id)
BI194122 epithelioid carcinoma cell line, Pancreas .c 128 to 758 1 to 633       633/767
(82 %)
15 diff
(98.1 %id)
BI194384 epithelioid carcinoma cell line, Pancreas .c 128 to 809 1 to 690       690/788
(87 %)
22 diff
(97.3 %id)
BI457160 epithelioid carcinoma cell line, Pancreas .c 128 to 737 1 to 614       614/812
(75 %)
19 diff
(97.7 %id)
CV027127 mixed .c 129 to 650 1 to 522       522/522
(100 %)
2 diff
(99.7 %id)
BG326198 Kidney, renal cell adenocarcinoma .c 129 to 642 1 to 527       527/527
(100 %)
21 diff
(96.1 %id)
CR981620 T-Lymphocytes .c 131 to 907 1 to 778       778/779
(99 %)
3 diff
(99.7 %id)
BF316077 brain, neuroblastoma .c 132 to 1010 1 to 867       867/1108
(78 %)
56 diff
(95.0 %id)
CN483313 eye .c 134 to 675 1 to 542       542/542
(100 %)
1 diff
(99.9 %id)
BQ436699 melanotic melanoma, skin .c 134 to 910 10 to 790   AAA   781/910
(85 %)
18 diff
(98.1 %id)
BG753368 eye, normal pigmented retinal epithelium .c 135 to 930 1 to 794       794/803
(98 %)
25 diff
(96.9 %id)
AA349876 brain .c 137 to 403 1 to 267       267/267
(100 %)
0 diff
(100 %id)
BF342097 brain, glioblastoma with EGFR amplification .c 137 to 783 1 to 647       647/647
(100 %)
3 diff
(99.6 %id)
BG675848 skin, squamous cell carcinoma .c 138 to 820 1 to 681       681/681
(100 %)
13 diff
(98.1 %id)
BQ898744 eye, normal pigmented retinal epithelium .c 138 to 910 1 to 777       777/954
(81 %)
16 diff
(98.4 %id)
CB270705 adipose .c 139 to 689 17 to 564       548/567
(96 %)
17 diff
(97.1 %id)
BG574043 breast, mammary adenocarcinoma, cell line .c 139 to 788 1 to 681       677/681
(99 %)
46 diff
(93.3 %id)
BG677571 skin, squamous cell carcinoma .c 139 to 964 1 to 826       824/826
(99 %)
33 diff
(96.1 %id)
BI222641 cervical carcinoma cell line, cervix .c 141 to 864 1 to 747       747/752
(99 %)
46 diff
(93.9 %id)
BE728637 melanotic melanoma, skin .c 143 to 885 1 to 739       739/800
(92 %)
11 diff
(98.7 %id)
BE743046 adenocarcinoma cell line, ovary .c 143 to 577 1 to 433       433/437
(99 %)
5 diff
(98.9 %id)
AW406525 lymph .c 144 to 559 9 to 424       416/424
(98 %)
15 diff
(96.5 %id)
BE794799 lung, small cell carcinoma .c 144 to 928 1 to 778       778/817
(95 %)
16 diff
(98.1 %id)
BG389057 embryonal carcinoma, cell line, testis .c 144 to 795 13 to 668       656/754
(87 %)
17 diff
(97.8 %id)
CD580367 brain .c 144 to 945 10 to 802       793/802
(98 %)
18 diff
(97.8 %id)
BE728187 melanotic melanoma, skin .c 145 to 721 1 to 579       579/953
(60 %)
20 diff
(98.0 %id)
BE745668 adenocarcinoma cell line, ovary .c 147 to 885 1 to 732       732/892
(82 %)
26 diff
(97.1 %id)
BE741159 adenocarcinoma cell line, ovary .c 147 to 701 1 to 555       555/555
(100 %)
0 diff
(100 %id)
BE740782 adenocarcinoma cell line, ovary .c 149 to 954 1 to 795       795/818
(97 %)
24 diff
(97.1 %id)
BU845069 ovary, teratocarcinoma, cell line .c 150 to 1055 1 to 912       912/912
(100 %)
8 diff
(99.2 %id)
ES314622 occipital scalp hair, skin .c 151 to 312 1 to 161       161/161
(100 %)
1 diff
(99.4 %id)
BU845241 ovary, teratocarcinoma, cell line .c 151 to 1013 1 to 873       873/938
(93 %)
23 diff
(97.6 %id)
CB268247 adipose .c 155 to 406 1 to 251       251/251
(100 %)
5 diff
(98.1 %id)
N99453 melanocyte .c 155 to 239 1 to 85       85/85
(100 %)
0 diff
(100 %id)
BE393329 endometrium, adenocarcinoma cell line, uterus .c 156 to 789 1 to 637       637/637
(100 %)
10 diff
(98.5 %id)
BG574245 breast, mammary adenocarcinoma, cell line .c 156 to 752 1 to 595       595/595
(100 %)
3 diff
(99.5 %id)
AA527471 colon .c 157 to 266 115 to 5       111/115
(96 %)
0 diff
(100 %id)
BF796423 lymph, lymphoma, cell line .c 159 to 877 1 to 713       713/934
(76 %)
11 diff
(98.9 %id)
CD106872 brain, Pituitary .c 160 to 941 1 to 793       793/838
(94 %)
19 diff
(97.8 %id)
R53313 whole brain .c 167 to 263 1 to 97       97/97
(100 %)
0 diff
(100 %id)
BM450963 eye, retinoblastoma .c 177 to 915 1 to 743       743/952
(78 %)
16 diff
(98.4 %id)
BQ278702 adenocarcinoma, cell line, breast .c 205 to 1159 1 to 964       964/1064
(90 %)
31 diff
(97.1 %id)
BQ951387 epidermoid carcinoma, cell line, lung .c 210 to 1071 1 to 875       875/972
(90 %)
23 diff
(97.7 %id)
BE273932 Kidney, renal cell adenocarcinoma .c 226 to 809 1 to 593       593/691
(85 %)
16 diff
(97.7 %id)
BG419170 Kidney, renal cell adenocarcinoma .c 232 to 961 1 to 727       727/932
(78 %)
34 diff
(96.4 %id)
BE514797 adenocarcinoma cell line, ovary .c 233 to 784 1 to 553       553/553
(100 %)
2 diff
(99.7 %id)
H17161 whole brain .c 265 to 593 1 to 342       342/342
(100 %)
18 diff
(94.8 %id)
CF456724 peripheral nervous system .c 304 to 1048 1 to 744       744/744
(100 %)
2 diff
(99.8 %id)
AL580641 T cells from T cell leukemia .c 350 to 1358 1036 to 28       1009/1038
(97 %)
10 diff
(99.1 %id)
CV328063 colon_est .c 355 to 709 1 to 355       355/355
(100 %)
31 diff
(91.3 %id)
BG167035 hypernephroma, cell line, Kidney .c 382 to 954 1 to 557       557/798
(69 %)
18 diff
(97.8 %id)
BE272289 adenocarcinoma cell line, ovary .c 389 to 1050 1 to 665       665/667
(99 %)
12 diff
(98.3 %id)
BG104852 adrenal cortex carcinoma, cell line, adrenal gland .c 395 to 838 1 to 444       444/444
(100 %)
2 diff
(99.6 %id)
BG284216 adenocarcinoma, cell line, Prostate .c 447 to 838 1 to 391       391/391
(100 %)
1 diff
(99.8 %id)
BM043731 carcinoma, cell line, Prostate .c 453 to 1235 2 to 784       783/784
(99 %)
8 diff
(99.0 %id)
BM047271 carcinoma, cell line, Prostate .c 453 to 1239 2 to 789       788/789
(99 %)
4 diff
(99.5 %id)
CF618824 Pooled Chondrosarcoma Tumor cells .c 462 to 1189 10 to 750       741/865
(85 %)
36 diff
(95.9 %id)
BM016246 breast, mammary adenocarcinoma, cell line .c 464 to 838 11 to 383       373/383
(97 %)
8 diff
(98.0 %id)
TI_59394650   .c 464 to 1215 62 to 810       749/760
(98 %)
17 diff
(97.8 %id)
AI342849 carcinoid, lung .c 474 to 842 1 to 369     Submitted on the opposite strand 369/369
(100 %)
1 diff
(99.8 %id)
TI_154103541   .c 491 to 1415 1004 to 89   AAA   916/994
(92 %)
23 diff
(97.7 %id)
BX402826   .c 494 to 1365 879 to 9       871/879
(99 %)
3 diff
(99.7 %id)
BU538252 adenocarcinoma, cell line, breast .c 517 to 1415 936 to 30   AAA Submitted on the opposite strand 907/935
(97 %)
21 diff
(97.8 %id)
BM018086 astrocytoma grade IV, cell line, brain .c 521 to 1131 1 to 614       614/717
(85 %)
9 diff
(98.8 %id)
TI_59388668   .c 521 to 1131 100 to 713       614/717
(85 %)
9 diff
(98.8 %id)
BI192899 epithelioid carcinoma cell line, Pancreas .c 523 to 1341 1 to 821       821/821
(100 %)
8 diff
(99.1 %id)
BI193045 epithelioid carcinoma cell line, Pancreas .c 523 to 1412 1 to 887   AAA   887/887
(100 %)
17 diff
(98.1 %id)
TI_1948074694   .c 523 to 948 550 to 124   fully sequenced,   427/550
(77 %)
0 diff
(100 %id)
TI_1948074506   .c 525 to 948 545 to 122   fully sequenced,   424/545
(77 %)
0 diff
(100 %id)
Z36821 Pancreas .c 541 to 805 1 to 267       267/320
(83 %)
22 diff
(93.2 %id)
CD624328   .c 542 to 1026 484 to 6       479/484
(98 %)
2 diff
(99.6 %id)
CD624329   .c 542 to 1026 1 to 483       483/489
(98 %)
10 diff
(98.0 %id)
BG029406 breast, mammary adenocarcinoma, cell line .c 566 to 1171 16 to 622       607/622
(97 %)
12 diff
(98.1 %id)
AL579475 T cells (Jurkat cell line), T cells from T cell leukemia .c 587 to 1377 793 to 1   fully sequenced,   793/793
(100 %)
4 diff
(99.5 %id)
TI_1948074320   .c 587 to 948 482 to 121   fully sequenced,   362/482
(75 %)
0 diff
(100 %id)
TI_1948074878   .c 587 to 948 481 to 120   fully sequenced,   362/481
(75 %)
0 diff
(100 %id)
AA445958   .c 599 to 1033 1 to 432       434/432
(100 %)
10 diff
(97.7 %id)
BM789000 Ascites, stomach .c 603 to 999 1 to 397       397/397
(100 %)
1 diff
(99.8 %id)
BM790400 Ascites, stomach .c 603 to 1104 1 to 502       502/502
(100 %)
5 diff
(99.1 %id)
BQ647287 hepatocellular carcinoma, cell line, Liver .c 606 to 1413 839 to 31   AAA Submitted on the opposite strand 809/870
(92 %)
13 diff
(98.6 %id)
BQ646043 hepatocellular carcinoma, cell line, Liver .c 606 to 1413 857 to 43   AAA Submitted on the opposite strand 815/844
(96 %)
22 diff
(97.4 %id)
BQ651917 hepatocellular carcinoma, cell line, Liver .c 606 to 1413 838 to 31   AAA Submitted on the opposite strand 808/863
(93 %)
20 diff
(97.7 %id)
BM928636 hepatocellular carcinoma, cell line, Liver .c 609 to 1413 834 to 31   AAA Submitted on the opposite strand 804/1015
(79 %)
9 diff
(99.2 %id)
TI_149285259   .c 625 to 1415 854 to 78   AAA   777/796
(97 %)
20 diff
(97.5 %id)
TI_149309910   .c 635 to 1415 856 to 84   AAA   773/960
(80 %)
12 diff
(98.8 %id)
AA427414 ovarian tumor, ovary .c 637 to 832 1 to 195       196/195
(100 %)
10 diff
(94.9 %id)
BY795567 eye .c 640 to 1115 1 to 476       476/476
(100 %)
2 diff
(99.6 %id)
BQ650153 hepatocellular carcinoma, cell line, Liver .c 646 to 1413 802 to 31   AAA Submitted on the opposite strand 772/823
(93 %)
21 diff
(97.5 %id)
BG925625 cartilage .c 670 to 1238 86 to 654       569/585
(97 %)
9 diff
(98.5 %id)
BU688268 lung .c 677 to 1415 751 to 17   AAA   735/737
(99 %)
4 diff
(99.5 %id)
AA300068 uterus .c 679 to 916 1 to 236       238/236
(100 %)
6 diff
(97.5 %id)
CN356642 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .c 683 to 1079 1 to 397       397/397
(100 %)
2 diff
(99.5 %id)
BE885663 leiomyosarcoma, uterus .c 686 to 818 1 to 132       132/132
(100 %)
1 diff
(99.3 %id)
CA422314 Bone, Enchondroma cell line .c 693 to 1415 741 to 19   AAA   723/723
(100 %)
4 diff
(99.5 %id)
AW246213 lung, small cell carcinoma .c 695 to 1251 10 to 566       557/566
(98 %)
10 diff
(98.3 %id)
BF569290 epithelioid carcinoma cell line, Pancreas .c 698 to 1370 670 to 1   fully sequenced,   670/670
(100 %)
14 diff
(98.0 %id)
CR975208 T-Lymphocytes .c 701 to 1355 1 to 656       656/663
(98 %)
5 diff
(99.3 %id)
BE263994 lung, small cell carcinoma .c 714 to 1403 1 to 722       679/728
(93 %)
64 diff
(91.3 %id)
BE264597 lung, small cell carcinoma .c 714 to 1381 1 to 697       697/779
(89 %)
29 diff
(96.3 %id)
BF057457 fibrotheoma, ovary .c 716 to 1413 700 to 1       700/701
(99 %)
13 diff
(98.2 %id)
BE208604 lung, small cell carcinoma .c 721 to 1160 1 to 440       440/440
(100 %)
6 diff
(98.7 %id)
BI769164 pooled lung and spleen .c 726 to 1413 1 to 689   AAA   689/689
(100 %)
8 diff
(98.9 %id)
TI_57178516   .c 728 to 1413 33 to 719   AAA   687/719
(95 %)
11 diff
(98.5 %id)
BF569309 epithelioid carcinoma cell line, Pancreas .c 729 to 1341 630 to 14       617/953
(64 %)
12 diff
(98.8 %id)
BQ644281 hepatocellular carcinoma, cell line, Liver .c 730 to 1413 736 to 49   AAA Submitted on the opposite strand 688/840
(81 %)
9 diff
(99.0 %id)
AA687478 normal prostate, Prostate .c 736 to 889 1 to 154       154/154
(100 %)
1 diff
(99.4 %id)
BQ220547 melanotic melanoma, skin .c 747 to 1413 1 to 667       667/671
(99 %)
5 diff
(99.3 %id)
CA428037 Bone, Subchondral Bone .c 759 to 1413 673 to 19   AAA   655/655
(100 %)
1 diff
(99.9 %id)
BQ575986 Chondrosarcoma Grade II, Left Pelvis .c 760 to 1415 674 to 19   AAA   656/656
(100 %)
6 diff
(99.1 %id)
CK725195 Chondrosarcoma, Left Pubic Bone .c 762 to 1415 670 to 17   AAA   654/654
(100 %)
4 diff
(99.4 %id)
BM984790 lung .c 799 to 1415 630 to 17   AAA   614/614
(100 %)
3 diff
(99.6 %id)
BG179522 adenocarcinoma, cell line, Prostate .c 800 to 1171 1 to 372       372/372
(100 %)
3 diff
(99.2 %id)
CA432052 cell lines, Enchondroma .c 811 to 1415 624 to 19   AAA   606/606
(100 %)
5 diff
(99.2 %id)
BI045930 prostate_normal .c 822 to 965 152 to 12       141/152
(92 %)
0 diff
(100 %id)
BG031400 breast, mammary adenocarcinoma, cell line .c 830 to 1413 1 to 582       582/757
(76 %)
5 diff
(99.4 %id)
AA552351 colon, tumor .c 843 to 1412 562 to 1       562/566
(99 %)
23 diff
(96.0 %id)
BI091305 cervix .c 846 to 1171 13 to 338       326/338
(96 %)
3 diff
(99.2 %id)
TI_149284369   .c 870 to 1420 631 to 80   AAA   552/803
(68 %)
6 diff
(99.3 %id)
CD671582 eye, Iris .c 878 to 1415 556 to 19   AAA   538/538
(100 %)
3 diff
(99.5 %id)
ES311647 frontal balding hair, skin .c 885 to 1028 1 to 143       143/143
(100 %)
1 diff
(99.4 %id)
BQ581275 insulinoma, Pancreas .c 885 to 1416 8 to 539       532/539
(98 %)
7 diff
(98.8 %id)
CK902071 insulinoma, Pancreas .c 885 to 1410 526 to 1       526/532
(98 %)
11 diff
(98.0 %id)
CK902072 insulinoma, Pancreas .c 885 to 1415 8 to 538   AAA   531/538
(98 %)
6 diff
(98.9 %id)
AA488920 germinal center B cell .c 887 to 1290 1 to 399   fully sequenced,   399/399
(100 %)
10 diff
(97.5 %id)
BU680530 lung .c 890 to 1420 550 to 19   AAA   532/532
(100 %)
6 diff
(98.9 %id)
CA748979 cell lines, Chondrosarcoma .c 896 to 1415 536 to 17   AAA   520/520
(100 %)
3 diff
(99.5 %id)
AI991822 colon, colonic mucosa from 3 patients with Crohn'sdisease .c 902 to 1421 523 to 4       520/523
(99 %)
0 diff
(100 %id)
AU144985 whole embryo, mainly head .c 919 to 1420 503 to 1       503/503
(100 %)
9 diff
(98.3 %id)
AW005567 anaplastic oligodendroglioma, brain .c 919 to 1415 510 to 14   AAA   497/497
(100 %)
12 diff
(97.6 %id)
AA847227 colon, colon tumor .c 937 to 1377 440 to 2       439/440
(99 %)
0 diff
(100 %id)
AA917665 adenocarcinoma, colon .c 945 to 1416 467 to 1       467/467
(100 %)
13 diff
(97.3 %id)
CD172735 embryonic stem cells, WA01, passage 38 .c 946 to 1420 23 to 497   AAA   475/497
(95 %)
6 diff
(98.8 %id)
BQ668816 epidermoid carcinoma, cell line, salivary gland .c 947 to 1416 1 to 470       470/971
(48 %)
11 diff
(98.9 %id)
AI760253 pooled .c 952 to 1410 474 to 16   AAA   459/459
(100 %)
3 diff
(99.4 %id)
AI144315 B-cell, chronic lymphotic leukemia .c 976 to 1414 442 to 4       439/442
(99 %)
0 diff
(100 %id)
AW150853 uterus, well-differentiated endometrialadenocarcinoma, 7 pooled tumors .c 976 to 1414 443 to 5       439/443
(99 %)
0 diff
(100 %id)
BU628597 Bone, Enchondroma cell line .c 982 to 1413 450 to 19   AAA   432/432
(100 %)
3 diff
(99.4 %id)
AA568169 colon, colon tumor RER+ .c 989 to 1421 433 to 6       428/433
(98 %)
0 diff
(100 %id)
BG028996 Bone, osteosarcoma, cell line .c 990 to 1414 1 to 424   AAA   424/424
(100 %)
5 diff
(98.9 %id)
BQ549426 insulinoma, Pancreas .c 990 to 1411 423 to 2       422/423
(99 %)
0 diff
(100 %id)
BU632424 cell lines, Chondrosarcoma .c 999 to 1413 431 to 17   AAA   415/415
(100 %)
3 diff
(99.3 %id)
AI056428 brain, glioblastoma (pooled) .c 1000 to 1416 417 to 1       417/417
(100 %)
3 diff
(99.3 %id)
BQ011533 placenta .c 1001 to 1413 431 to 19   AAA   413/413
(100 %)
4 diff
(99.1 %id)
AA371201 Prostate .c 1004 to 1220 1 to 217       217/219
(99 %)
5 diff
(97.8 %id)
AI811247 poorly-differentiated endometrialadenocarcinoma, 2 pooled tumors, uterus .c 1006 to 1413 425 to 18   AAA   408/408
(100 %)
2 diff
(99.6 %id)
AW276233 lung, two pooled squamous cell carcinomas .c 1008 to 1416 416 to 8       409/416
(98 %)
0 diff
(100 %id)
AW027429 thymus, pooled .c 1012 to 1416 407 to 3       405/407
(99 %)
0 diff
(100 %id)
AW083270 colon, moderately differentiated adenocarcinoma .c 1012 to 1416 412 to 7       406/412
(98 %)
0 diff
(100 %id)
AI480232 anaplastic oligodendroglioma, brain .c 1014 to 1414 407 to 7       401/407
(98 %)
0 diff
(100 %id)
AI198367 anaplastic oligodendroglioma, brain .c 1016 to 1414 404 to 6       399/404
(98 %)
0 diff
(100 %id)
AI041893 mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus .c 1017 to 1416 402 to 3       400/402
(99 %)
0 diff
(100 %id)
AW962896   .c 1018 to 1334 1 to 317       317/318
(99 %)
8 diff
(97.5 %id)
AA113999 Pancreas .c 1022 to 1390 363 to 1       363/363
(100 %)
11 diff
(97.0 %id)
BM723992 eye, fetal eye .c 1023 to 1415 1 to 399   AAA   399/399
(100 %)
10 diff
(97.5 %id)
W92520 heart .c 1028 to 1415 390 to 1       390/391
(99 %)
19 diff
(95.2 %id)
AA427415 ovarian tumor, ovary .c 1028 to 1393 361 to 1       361/361
(100 %)
7 diff
(98.1 %id)
AA946875 2 pooled tumors (clear cell type), Kidney .c 1037 to 1416 380 to 4       377/380
(99 %)
0 diff
(100 %id)
AA430213   .c 1039 to 1413 393 to 20   AAA   374/374
(100 %)
8 diff
(97.9 %id)
AA604545 lung, lung tumor .c 1042 to 1377 336 to 3       334/338
(98 %)
0 diff
(100 %id)
AA662705 normal prostate, Prostate .c 1046 to 1390 343 to 1       343/343
(100 %)
7 diff
(98.0 %id)
AA516013 colon .c 1052 to 1413 372 to 13   AAA   360/360
(100 %)
7 diff
(98.1 %id)
AI032102 liver and spleen .c 1070 to 1413 344 to 1       344/344
(100 %)
5 diff
(98.6 %id)
F28974 pectoral muscle (after mastectomy) .c 1076 to 1409 1 to 333       333/333
(100 %)
4 diff
(98.8 %id)
CV574533 cornea, eye .c 1093 to 1415 1 to 323   AAA   323/323
(100 %)
0 diff
(100 %id)
AA676954 whole brain .c 1107 to 1396 288 to 1       288/288
(100 %)
6 diff
(98.0 %id)
AI971135 Prostate .c 1108 to 1416 310 to 2       309/310
(99 %)
0 diff
(100 %id)
BF939307 Prostate .c 1108 to 1416 312 to 4       309/312
(99 %)
0 diff
(100 %id)
BI912634 leukocyte .c 1109 to 1406 321 to 605       543/605
(89 %)
21 diff
(96.6 %id)
TI_57247385   .c 1109 to 1406 321 to 605       543/605
(89 %)
21 diff
(96.6 %id)
N99524 liver and spleen .c 1111 to 1410 1 to 296       296/296
(100 %)
11 diff
(96.3 %id)
EC484412 Prostate .c 1114 to 1198 1 to 84       84/84
(100 %)
1 diff
(98.9 %id)
AI186416 placenta .c 1119 to 1309 191 to 1       191/191
(100 %)
1 diff
(99.5 %id)
H17946 whole brain .c 1121 to 1413 324 to 29   AAA   296/301
(98 %)
7 diff
(97.7 %id)
AI749378 aorta .c 1124 to 1411 289 to 1       289/337
(85 %)
10 diff
(97.1 %id)
AJ572689 pectoral muscle (after mastectomy) .c 1126 to 1285 1 to 156       156/156
(100 %)
9 diff
(94.3 %id)
AW050759 colon, colonic mucosa from 3 patients with Crohn'sdisease .c 1131 to 1416 290 to 5       286/290
(98 %)
0 diff
(100 %id)
AW075249 anaplastic oligodendroglioma, brain .c 1136 to 1415 282 to 1       282/282
(100 %)
4 diff
(98.6 %id)
AA703568 liver and spleen .c 1145 to 1379 231 to 1       231/231
(100 %)
7 diff
(97.0 %id)
AA903416 leiomyosarcoma, soft tissue .c 1168 to 1415 261 to 16   AAA   246/246
(100 %)
7 diff
(97.2 %id)
AI866021 uterus, well-differentiated endometrialadenocarcinoma, 7 pooled tumors .c 1190 to 1414 225 to 1       225/225
(100 %)
2 diff
(99.2 %id)
F19320 pectoral muscle (after mastectomy) .c 1193 to 1416 1 to 224       224/224
(100 %)
3 diff
(98.7 %id)
AW078903 2 pooled Wilms' tumors, one primary and onemetastatic to brain, Kidney .c 1194 to 1415 244 to 23   AAA   222/222
(100 %)
6 diff
(97.3 %id)
BE645932 Prostate .c 1201 to 1399 217 to 19       199/217
(91 %)
0 diff
(100 %id)
BF439443 pooled .c 1206 to 1416 211 to 1       211/211
(100 %)
0 diff
(100 %id)
AA411354 ovarian tumor, ovary .c 1207 to 1415 208 to 1       208/208
(100 %)
8 diff
(96.2 %id)
BM856872 stomach .c 1230 to 1397 1 to 168       168/168
(100 %)
2 diff
(98.9 %id)
N71680 melanocyte .c 1232 to 1413 178 to 1       178/178
(100 %)
8 diff
(95.6 %id)
BI257466 cervical carcinoma cell line, cervix .c 1235 to 1415 1 to 182   AAA   182/182
(100 %)
3 diff
(98.4 %id)
BG032561 breast, mammary adenocarcinoma, cell line .c 1249 to 1415 1 to 168   AAA   168/168
(100 %)
3 diff
(98.3 %id)
BM987719 mixed .c 1256 to 1420 183 to 19   AAA   165/165
(100 %)
1 diff
(99.4 %id)
AA488849 germinal center B cell .c 1260 to 1415 188 to 34   fully sequenced, AAA   155/155
(100 %)
3 diff
(98.1 %id)
BM690333 eye, human retina .c 1285 to 1415 1 to 131   AAA   131/131
(100 %)
1 diff
(99.3 %id)
AA913234 pooled .c 1334 to 1416 86 to 4       83/86
(96 %)
0 diff
(100 %id)
AW087551 colon, moderately differentiated adenocarcinoma .c 1351 to 1410 60 to 1       60/60
(100 %)
2 diff
(96.7 %id)
BP202392 amygdala .d 1 to 581 2 to 582   tiling clone,   582/582
(100 %)
2 diff
(99.7 %id)
CR618786 Neuroblastoma Cot 50-normalized .d 7 to 1172 1 to 1166   tiling clone,   1166/1166
(100 %)
0 diff
(100 %id)
BX334078 Neuroblastoma Cot 50-normalized .d 7 to 1044 1 to 1032       1032/1085
(95 %)
49 diff
(95.5 %id)
BG419500 Kidney, renal cell adenocarcinoma .d 14 to 830 1 to 813       813/1138
(71 %)
41 diff
(96.4 %id)
CA454482   .d 16 to 377 1 to 361       361/941
(38 %)
5 diff
(99.5 %id)
CD246427 embryonic stem cells, WA01, passage 38 .d 24 to 888 15 to 881       867/881
(98 %)
16 diff
(98.2 %id)
T80366 whole brain .d 26 to 368 1 to 338       338/338
(100 %)
14 diff
(95.9 %id)
BG282159 melanotic melanoma, skin .d 26 to 857 1 to 829       829/829
(100 %)
23 diff
(97.3 %id)
BE731561 choriocarcinoma, placenta .d 28 to 423 1 to 402       400/843
(47 %)
11 diff
(98.7 %id)
TI_57151966   .d 32 to 571 26 to 563       538/563
(95 %)
8 diff
(98.6 %id)
CB142635 Liver .d 35 to 395 1 to 361       361/361
(100 %)
3 diff
(99.2 %id)
CN356643 embryonic stem cells, DMSO-treated H9 cellline .d 36 to 729 1 to 694       694/694
(100 %)
3 diff
(99.6 %id)
BI763231 pooled colon, kidney, stomach .d 36 to 571 1 to 534       534/534
(100 %)
3 diff
(99.5 %id)
BQ672399 epidermoid carcinoma, cell line, salivary gland .d 37 to 615 1 to 580       580/988
(58 %)
15 diff
(98.5 %id)
BQ668559 epidermoid carcinoma, cell line, salivary gland .d 37 to 746 1 to 720       720/942
(76 %)
21 diff
(97.8 %id)
DN993755 brain, whole brain .d 44 to 663 8 to 627       620/627
(98 %)
7 diff
(98.9 %id)
DC394418 esophageal, tumor tissue .d 52 to 619 5 to 572       568/572
(99 %)
12 diff
(98.0 %id)
CR986861 T-Lymphocytes .d 54 to 817 1 to 766       766/767
(99 %)
4 diff
(99.5 %id)
CR590570 Neuroblastoma Cot 10-normalized .d 55 to 1160 1 to 1106       1106/1106
(100 %)
0 diff
(100 %id)
AL521553 brain, neuroblastoma cells, Neuroblastoma Cot 10-normalized .d 55 to 520 1 to 465   fully sequenced,   465/465
(100 %)
2 diff
(99.6 %id)
TI_57200620   .d 55 to 970 63 to 964       902/964
(93 %)
24 diff
(97.6 %id)
AK300696 skeletal muscle .d 58 to 1073 1 to 1016       1016/1016
(100 %)
0 diff
(100 %id)
DC385767 skeletal muscle .d 58 to 623 1 to 566       566/566
(100 %)
0 diff
(100 %id)
BI821469 pooled brain, lung, testis .d 61 to 970 1 to 896       896/896
(100 %)
18 diff
(98.0 %id)
BM908707 astrocytoma grade IV, cell line, brain .d 64 to 986 4 to 929       926/1103
(83 %)
38 diff
(96.6 %id)
BQ072662 leukocyte .d 65 to 978 13 to 934       922/1072
(86 %)
41 diff
(96.2 %id)
CN356647 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .d 67 to 756 1 to 691       691/691
(100 %)
2 diff
(99.8 %id)
BM909044 astrocytoma grade IV, cell line, brain .d 72 to 856 1 to 796       796/1140
(69 %)
32 diff
(97.2 %id)
BQ918823 brain, neuroblastoma, cell line .d 72 to 981 1 to 919       919/961
(95 %)
31 diff
(96.8 %id)
BQ920513 epidermoid carcinoma, cell line, lung .d 77 to 1011 1 to 942       942/943
(99 %)
32 diff
(96.7 %id)
CN356639 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .d 92 to 834 1 to 744       744/744
(100 %)
3 diff
(99.6 %id)
BE259781 brain, neuroblastoma .d 96 to 734 1 to 637       637/638
(99 %)
14 diff
(97.9 %id)
BE796064 lung, small cell carcinoma .d 96 to 844 1 to 747       747/750
(99 %)
11 diff
(98.6 %id)
BQ694294 adipose .d 98 to 448 1 to 350       350/350
(100 %)
2 diff
(99.5 %id)
R73441 breast .d 98 to 352 1 to 256       256/256
(100 %)
7 diff
(97.3 %id)
BE799414 lung, small cell carcinoma .d 99 to 949 42 to 880       839/993
(84 %)
33 diff
(96.7 %id)
TI_57189843   .d 104 to 918 54 to 868       815/869
(93 %)
16 diff
(98.2 %id)
BI859786 breast, mammary adenocarcinoma, cell line .d 105 to 599 1 to 495       495/495
(100 %)
1 diff
(99.8 %id)
CX872888 embryonic stem .d 105 to 982 1 to 878       878/878
(100 %)
2 diff
(99.8 %id)
CA455299 adenocarcinoma, cell line, breast .d 216 to 973 1 to 760       760/889
(85 %)
23 diff
(97.5 %id)
AL521552 brain, neuroblastoma cells, Neuroblastoma Cot 10-normalized .d 459 to 1160 701 to 1   fully sequenced,   701/701
(100 %)
12 diff
(98.3 %id)
R73442 breast .d 926 to 1175 254 to 7   tiling clone,   248/254
(97 %)
0 diff
(100 %id)
BQ067360 pooled brain, lung, testis .e 1 to 511 1 to 512 A156G L157P V158R V159G T160H ... tiling clone,   807/1183
(68 %)
14 diff
(98.9 %id)
BE266149 lung, small cell carcinoma .f 1 to 537 1 to 537   tiling clone,   537/537
(100 %)
0 diff
(100 %id)
BM470860 eye, retinoblastoma .f 5 to 914 41 to 962   tiling clone,   922/1042
(88 %)
30 diff
(97.2 %id)
DR761562 embryonic stem .g 1 to 812 1 to 812 exact tiling clone,   812/812
(100 %)
7 diff
(99.2 %id)
CR616284 HeLa cells Cot 25-normalized .h 1 to 1732 1 to 1732 exact tiling clone,   1732/1732
(100 %)
0 diff
(100 %id)
AL555414 placenta .h 1 to 867 1 to 862   fully sequenced,   862/862
(100 %)
9 diff
(99.0 %id)
AL555413 placenta .h 837 to 1732 890 to 1   fully sequenced,   890/890
(100 %)
25 diff
(97.2 %id)
BX446436 placenta .i 1 to 1025 8 to 1016 S31F E113D L114X T115P F116S ... tiling clone,   1016/1029
(98 %)
45 diff
(95.7 %id)
DA609192   .i 1 to 551 5 to 557   tiling clone, capped   556/561
(99 %)
4 diff
(99.3 %id)
BG818869 anaplastic oligodendroglioma with 1p/19qloss, brain .j 1 to 816 13 to 816   tiling clone,   804/822
(97 %)
23 diff
(97.3 %id)
BI196883 brain, neuroblastoma .k 1 to 583 1 to 585 G134E T136S R151S R152P A154C ... tiling clone,   585/586
(99 %)
12 diff
(98.0 %id)
BU617559 Bone, Subchondral Bone .l 1 to 713 732 to 19 Q16P R18A R19A R20E G21R ... tiling clone, AAA   714/714
(100 %)
2 diff
(99.8 %id)
DA894649 skeletal muscle .m 1 to 469 2 to 470   tiling clone, capped   469/469
(100 %)
0 diff
(100 %id)
BF971760 leiomyosarcoma cell line, uterus .m 8 to 609 1 to 596 exact tiling clone,   596/609
(97 %)
11 diff
(98.2 %id)
BF972798 leiomyosarcoma cell line, uterus .m 8 to 560 1 to 553 exact tiling clone,   677/683
(99 %)
11 diff
(98.4 %id)
AK124460 cerebellum .n-u 1 to 2229 7 to 2239 V133F P134G V135S N137* tiling clone, available from FLJ,   2239/2239
(100 %)
19 diff
(99.2 %id)
DA077893 cerebellum .n-u 1 to 548 7 to 554   capped   553/553
(100 %)
13 diff
(97.7 %id)
DB152339 thymus .n-u 1 to 581 2 to 583   capped   582/582
(100 %)
12 diff
(98.0 %id)
CX166382 human embryonic stem cells differentiated toan early endodermal cell type .n-u 119 to 923 1 to 805   tiling clone,   805/805
(100 %)
7 diff
(99.2 %id)
DA108231 cerebellum .n-u 175 to 746 2 to 578   capped   577/577
(100 %)
13 diff
(97.8 %id)
DB286476 uterus .n-u 346 to 882 2 to 539   tiling clone, capped   538/538
(100 %)
1 diff
(99.9 %id)
DA323282 hippocampus .n-u 411 to 879 2 to 470   capped   469/469
(100 %)
1 diff
(99.8 %id)
DA007122   .n-u 607 to 1168 2 to 563   capped   562/562
(100 %)
1 diff
(99.9 %id)
DA116172 cerebellum .n-u 798 to 1381 2 to 585   capped   584/584
(100 %)
0 diff
(100 %id)
DA116179 cerebellum .n-u 798 to 1176 2 to 380   capped   379/379
(100 %)
0 diff
(100 %id)
DA297644 hippocampus .n-u 837 to 1414 2 to 579   capped   578/578
(100 %)
0 diff
(100 %id)
BF808095 colon_ins .n-u 909 to 1211 304 to 1     Submitted on the opposite strand 304/304
(100 %)
9 diff
(97.1 %id)
CN287441 embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells .n-u 1312 to 1803 1 to 496       496/496
(100 %)
5 diff
(99.0 %id)
DB297816 cerebellum .n-u 1711 to 2229 519 to 1       519/519
(100 %)
2 diff
(99.7 %id)
DB111979 thymus .o 1 to 541 2 to 542   tiling clone, capped   541/541
(100 %)
2 diff
(99.7 %id)
DA829180 placenta .o 13 to 707 2 to 698   tiling clone, capped   697/698
(99 %)
12 diff
(98.3 %id)
DA588587 lung .o 35 to 595 2 to 562   tiling clone, capped   561/561
(100 %)
0 diff
(100 %id)
DB168393 kidney, tumor tissue .o 38 to 630 2 to 594   tiling clone, capped   593/593
(100 %)
1 diff
(99.9 %id)
DA031692   .o 44 to 595 2 to 553   capped   552/552
(100 %)
1 diff
(99.9 %id)
AU156180 placenta .o 1733 to 2072 340 to 1   tiling clone,   340/340
(100 %)
2 diff
(99.5 %id)
AK093593 thymus .p 1 to 2195 2 to 2196 exact tiling clone, available from FLJ,   2196/2196
(100 %)
6 diff
(99.8 %id)
AX748219   .p 1 to 2195 2 to 2196 exact     2196/2196
(100 %)
6 diff
(99.8 %id)
DB103420 thymus .p 1 to 559 2 to 561   capped   560/560
(100 %)
3 diff
(99.5 %id)
CR995956 T-Lymphocytes .p 10 to 557 1 to 548       548/548
(100 %)
2 diff
(99.7 %id)
DA936309 Spleen .p 12 to 603 2 to 595   capped   594/594
(100 %)
8 diff
(98.7 %id)
DB110639 thymus .p 16 to 591 2 to 578   capped   577/577
(100 %)
3 diff
(99.5 %id)
BP374668 umbilical cord .p 19 to 602 1 to 583       583/583
(100 %)
4 diff
(99.4 %id)
DA041523 bladder .p 25 to 530 2 to 508   capped   507/507
(100 %)
3 diff
(99.5 %id)
TI_57176415   .p 28 to 672 80 to 717       638/720
(88 %)
21 diff
(97.1 %id)
DA371392 thalamus .p 29 to 579 2 to 553   tiling clone, capped   552/552
(100 %)
2 diff
(99.7 %id)
DA947769 Spleen .p 29 to 591 2 to 564   capped   563/563
(100 %)
2 diff
(99.7 %id)
BP230313 brain .p 31 to 613 1 to 582       582/582
(100 %)
5 diff
(99.2 %id)
BI829849 brain, medulla .p 36 to 672 1 to 633       633/636
(99 %)
20 diff
(96.9 %id)
DB108857 thymus .p 36 to 612 2 to 578   capped   577/577
(100 %)
3 diff
(99.5 %id)
DB102248 thymus .p 37 to 593 2 to 558   capped   557/557
(100 %)
2 diff
(99.7 %id)
BX648907 human salivary gland .p 45 to 2197 1 to 2153 A23G tiling clone, available from DKFZ, AAA   2153/2153
(100 %)
9 diff
(99.6 %id)
DA546780   .p 51 to 585 2 to 536   capped   535/535
(100 %)
2 diff
(99.7 %id)
DA874503 Prostate .p 51 to 605 2 to 556   capped   555/555
(100 %)
2 diff
(99.7 %id)
DB211503 trachea .p 51 to 377 2 to 328   capped   327/327
(100 %)
2 diff
(99.4 %id)
DA934349 Spleen .p 57 to 626 2 to 571   capped   570/570
(100 %)
3 diff
(99.5 %id)
BP341067 stomach mucosa .p 57 to 638 1 to 580       580/580
(100 %)
3 diff
(99.5 %id)
DB112784 thymus .p 58 to 619 2 to 563   capped   562/562
(100 %)
3 diff
(99.5 %id)
BI767553 pooled lung and spleen .p 326 to 1233 1 to 916       916/916
(100 %)
26 diff
(97.2 %id)
TI_57184288   .p 326 to 1233 67 to 982       916/982
(93 %)
9 diff
(99.1 %id)
CN356644 embryonic stem cells, DMSO-treated H9 cellline .p 942 to 1632 1 to 690       690/690
(100 %)
4 diff
(99.5 %id)
DB342648 thymus .p 1614 to 2195 584 to 1       584/584
(100 %)
8 diff
(98.7 %id)
DA366535 subthalamic nucleus .q 1 to 510 2 to 511 P65T tiling clone, capped   510/510
(100 %)
1 diff
(99.9 %id)
CN267940 embryonic stem cells, cell lines H1, H7, andH9 .r-u 1 to 560 1 to 560 exact tiling clone,   560/560
(100 %)
2 diff
(99.7 %id)
DA340108 hippocampus .s 1 to 536 2 to 538 N6D H8R S11G S13G S14G ... tiling clone, capped   537/537
(100 %)
19 diff
(96.5 %id)
BE047940 brain, tumor, 5 pooled (see description) Gene NUBP2, variant not shown       fully sequenced, Suspected internal deletion, this clone was ignored    
AI863189 brain, tumor, 5 pooled (see description) Gene NUBP2, variant not shown       fully sequenced, Suspected internal deletion, this clone was ignored    
BF001891 colon, colon tumor, RER+ Gene NUBP2, variant not shown         Suspected internal deletion, this clone was ignored    
BI908537 leukocyte Gene NUBP2, variant not shown         Suspected internal deletion, this clone was ignored    
TI_57237207   Gene NUBP2, variant not shown         Suspected internal deletion, this clone was ignored    
? Gene Summary Gene on genome mRNA:.a, .b, .c, .d, .e, .f, .g, .h, .i, .j, .k, .l, .m, .n-u, .o, .p, .q, .r-u, .s Alternative mRNAs features, proteins, introns, exons, sequences Expression Tissue Function, regulation, related genes C